TACROLIMUS 0.1%w/w IP

A class of non-steroidal topical immunomodulators that is indicated for the treatment of atopic dermatitis. (A Kapp, 2003) Exerts a rapid onset of action with sustained therapeutic effects. (Nakagawa, 2006) An effective treatment for atopic dermatitis of the trunk and limbs, as well as sensitive skin areas such as the face. (Dene Simpson, 2005) An alternative to conventional topical corticosteroid therapy. (A Kapp, 2003) Offers excellent improvement in psoriatic lesions of the face or intertriginous areas in psoriasis individuals. (Mark Lebwohl, 2004) Promptly reduces the incidence of flares and treats the signs and symptoms of atopic dermatitis. (A Kapp, 2003) Significantly more effective than 1% hydrocortisone acetate in the treatment of moderate-to-severe atopic dermatitis. (Sakari Reitamo, 2002) A safe and effective for short- and long-term treatment of atopic dermatitis in pediatric and adult patients. (J C Pascual, 2004) More effective and has a faster onset of action than pimecrolimus cream in adults and children with atopic dermatitis. (Amy S Paller, 2005)